Scarica l'app Stockscreener
2.17
7.66%
-0.18
Dopo l'orario di chiusura:
2.36
0.19
+8.76%
Precedente Chiudi:
$2.35
Aprire:
$2.31
Volume 24 ore:
135.74K
Relative Volume:
0.09
Capitalizzazione di mercato:
$22.59M
Reddito:
-
Utile/perdita netta:
$-45.57M
Rapporto P/E:
-0.3444
EPS:
-6.3
Flusso di cassa netto:
$-38.56M
1 W Prestazione:
-13.20%
1M Prestazione:
+0.93%
6M Prestazione:
+56.12%
1 anno Prestazione:
-30.23%
Intervallo 1D:
$2.17
$2.4649
Intervallo di 1 settimana:
$2.17
$2.59
Portata 52W:
$1.00
$6.60
Sab Biotherapeutics Inc Stock (SABS) Company Profile
Nome
Sab Biotherapeutics Inc
Settore
Industria
Telefono
305-845-2813
Indirizzo
777 W 41ST ST, MIAMI BEACH
Confronta SABS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SABS
Sab Biotherapeutics Inc
|
2.17 | 23.95M | 0 | -45.57M | -38.56M | -6.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Sab Biotherapeutics Inc Stock (SABS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-17 | Iniziato | Leerink Partners | Outperform |
| 2025-05-14 | Ripresa | H.C. Wainwright | Buy |
| 2024-10-09 | Iniziato | Craig Hallum | Buy |
| 2024-08-28 | Iniziato | Oppenheimer | Outperform |
| 2021-11-05 | Iniziato | Chardan Capital Markets | Buy |
Sab Biotherapeutics Inc Borsa (SABS) Ultime notizie
Can SAB Biotherapeutics Inc. Equity Warrant stock resist sector downturnsInflation Watch & Weekly Momentum Stock Picks - newser.com
Will SAB Biotherapeutics Inc. stock deliver consistent dividends2025 Risk Factors & Trade Opportunity Analysis Reports - newser.com
How sustainable is SAB Biotherapeutics Inc. Equity Warrant stock dividend payoutPortfolio Update Report & Free Daily Entry Point Trade Alerts - newser.com
How SAB Biotherapeutics Inc. Equity Warrant stock performs in interest rate cyclesJuly 2025 Patterns & Safe Entry Momentum Tips - newser.com
Will SAB Biotherapeutics Inc. Equity Warrant stock benefit from sector rotationDay Trade & Weekly Market Pulse Updates - newser.com
Will breakout in SAB Biotherapeutics Inc. lead to full recoveryMarket Rally & Fast Exit Strategy with Risk Control - newser.com
SAB Biotherapeutics (NASDAQ:SABS) Receives “Sell (E+)” Rating from Weiss Ratings - Defense World
Will SAB Biotherapeutics Inc. Equity Warrant stock benefit from upcoming earnings reportsInflation Watch & Consistent Return Investment Signals - newser.com
Can SAB Biotherapeutics Inc. stock sustain institutional interestMarket Sentiment Summary & Consistent Growth Equity Picks - newser.com
How to build a custom watchlist for SAB Biotherapeutics Inc. Equity WarrantPortfolio Risk Summary & Short-Term Swing Trade Alerts - newser.com
Will SAB Biotherapeutics Inc. stock see PE expansion2025 Market WrapUp & Precise Buy Zone Identification - newser.com
What technical models suggest about SAB Biotherapeutics Inc. Equity Warrant’s comebackPortfolio Update Summary & Verified High Yield Trade Plans - newser.com
Why retail investors pile into SAB Biotherapeutics Inc. stockEarnings Growth Summary & Growth-Oriented Investment Plans - newser.com
How to monitor SAB Biotherapeutics Inc. with trend dashboards2025 Trading Volume Trends & Entry Point Confirmation Signals - newser.com
Tick level data insight on SAB Biotherapeutics Inc. volatilityWeekly Profit Summary & Real-Time Buy Signal Alerts - newser.com
Is SAB Biotherapeutics Inc. stock bottoming outJuly 2025 Snapshot & Free High Accuracy Swing Entry Alerts - newser.com
SAB Biotherapeutics Inc. Equity Warrant stock outlook for YEARWeekly Trade Report & AI Powered Buy/Sell Recommendations - newser.com
Is SAB Biotherapeutics Inc a good long term investmentInsider Trading Activity & Big Profit Low Investment - earlytimes.in
Should you wait for a breakout in SAB Biotherapeutics Inc.Quarterly Earnings Report & Risk Controlled Daily Plans - newser.com
Using Ichimoku Cloud for SAB Biotherapeutics Inc. Equity Warrant technicalsWeekly Trade Recap & Precise Buy Zone Identification - newser.com
How to track smart money flows in SAB Biotherapeutics Inc. Equity WarrantJuly 2025 EndofMonth & Weekly Top Gainers Alerts - newser.com
Is SAB Biotherapeutics Inc. stock reversal real or fake2025 Market Outlook & Risk Managed Investment Strategies - newser.com
COMMODORE CAPITAL LP Acquires Significant Stake in SAB Biotherapeutics Inc - GuruFocus
RA CAPITAL MANAGEMENT, L.P. Acquires Significant Stake in SAB Bi - GuruFocus
Will SAB Biotherapeutics Inc. Equity Warrant stock recover after recent dropWeekly Trade Summary & Verified Short-Term Trading Plans - newser.com
Will SAB Biotherapeutics Inc. Equity Warrant bounce back from current supportJuly 2025 Review & Daily Technical Forecast Reports - newser.com
How to interpret RSI for SAB Biotherapeutics Inc. stockTrade Volume Report & Real-Time Sentiment Analysis - newser.com
Advanced analytics toolkit walkthrough for SAB Biotherapeutics Inc.Market Growth Summary & Real-Time Chart Breakout Alerts - newser.com
Is SAB Biotherapeutics Inc. stock entering bullish territoryWeekly Risk Report & Weekly Top Gainers Trade List - newser.com
Published on: 2025-10-09 02:46:01 - newser.com
What drives SAB Biotherapeutics Inc stock priceIPO Market Watch & High Return Trading Ideas - earlytimes.in
Can technical indicators confirm SAB Biotherapeutics Inc.’s reversalEarnings Recap Summary & Risk Managed Investment Entry Signals - newser.com
Institutional scanner results for SAB Biotherapeutics Inc. Equity Warrant2025 Historical Comparison & Reliable Intraday Trade Plans - newser.com
Strategies to average down on SAB Biotherapeutics Inc. Equity WarrantWeekly Loss Report & Community Verified Swing Trade Signals - newser.com
Will SAB Biotherapeutics Inc. see short term momentumDollar Strength & Fast Entry High Yield Stock Tips - newser.com
Full technical analysis of SAB Biotherapeutics Inc. stockJuly 2025 Decliners & Target Return Focused Picks - newser.com
Will a bounce in SAB Biotherapeutics Inc. Equity Warrant offer an exit2025 Pullback Review & Expert Approved Momentum Ideas - newser.com
Using data filters to optimize entry into SAB Biotherapeutics Inc.Entry Point & Advanced Technical Signal Analysis - newser.com
Published on: 2025-10-05 04:55:13 - newser.com
Is SAB Biotherapeutics Inc. Equity Warrant stock a buy in volatile markets2025 Key Lessons & Low Risk High Win Rate Picks - newser.com
Sab Biotherapeutics Inc Azioni (SABS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Sab Biotherapeutics Inc Azioni (SABS) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Sessa Capital (Master), L.P. | Director |
Sep 29 '25 |
Option Exercise |
1.75 |
1,740,000 |
3,045,000 |
2,198,457 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):